RE:RE:Theralase Safety During Market Erosion Yup, this is it. The final countdown. What we LONGS have been here for sooooo many years. Bought too early, maybe, but believed in the dream, and the long term Goal. These next 1-4 months should tell us the optimised story, and some durability data, which then should hopefully start to drive some serious SP appreciation.
ScienceFirst wrote: Data on 11 patients that had received their 2nd dose but for which we had not received yet a status should be THE focus to watch on whether they turned CR @270 days on how many of them (%) reached this CR. The % would help assess what we could expect from optimized patients group. That could be very telling.